Favipiravir CAS 259793-96-9 T-705 Puritas ≥99.0% (HPLC) COVID-19 API Factory High Quality

Description:

Chemical Name: Favipiravir;T-705

CAS: 259793-96-9

Aspectus: Alba ad Off-White pulveris

Puritas: ≥99.0% (HPLC)

In curatione De Viris Illustribus Infectionibus et COVID-19

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer cum High puritate et stabulo Quality
Commercial Supple Favipiravir et intermedia:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonatum Hydrochloridum CAS 13433-00-6
3,6-Dichloropyrazinum-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS, 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Chemical Properties:

Nomen chemicum	Favipiravir
Synonyma	T-705;6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide
CAS Number	259793-96-9
CATTUS Number	RF-API18
Stock Status	In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae	C5H4FN3O2
M. Pondus	157.1
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Off-White pulveris
Lepidium sativum 1H-NMR	Congruunt propositus structuram
Lepidium sativum HPLC	Retentionis tempus praecipuum cacumen in sample praeparatione congruere debet cum retentione temporis praecipui apicem in comparatione vexillum praeparatio
Lepidium sativum	Massa Imaginis structurae propositae stat
Liquescens punctum	188.0℃-193.0℃
Substantiae cognatae (Area Normalization)	Quaelibet impuritas: ≤0.10% (HPLC)
Substantiae cognatae (Area Normalization)	Totalis immunditias: ≤1.0% (HPLC)
Puritas / Analysis Methodus	≥99.0% (HPLC)
Humor (KF)	≤0.50%
Residere in Ignition	≤0.10%
Metalla gravis	≤20ppm
Residuum Solvents
Methanol	≤3000ppm
Isopropanol	≤5000ppm
n-Heptane	≤5000ppm
Ethanol	≤5000ppm
Test Standard	Enterprise Standard
Consuetudinem	Active Pharmaceutical Ingredient (API);Curatio COVID-19

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/tympanum Cardboard, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Favipiravir (T-705) (CAS 259793-96-9) unus e 5 compositionibus commendatur ab QUI ad inquisitionem tractationis de COVID-19.Favipiravir inhibitor selectivi virialis RNA-dependens RNA polymerasium cum actione contra multos RNA virus, influentiam virus, virus Nili occidentale, virus febris flavi, virus morbi pedis et oris necnon aliae flaviviroses, arenavirosos, bunyaviruses et alphaviruses.Favipiravir medicamentum latum-spectrum antivirale est quod medicinae moderatoris Generalis Indiae (DCGI) proxima septimana purgatum est pro usu inter aegros Covid-19 subitis.Favipiravir in recentibus 1990s primum processit a societate quae postea a firma Fujifilm Iaponica acquisita est ut pars eius transitus e negotio phocatico ad curis.Post probatum contra varias virus virus, medicamentum in Iaponia anno 2014 probatum est ad usus necessarios contra morbos epidemicos vel novos modos influentiae tractandas.